NCT02232139

Brief Summary

The aim of the investigation is to validate the SmartPhone-based 4-Reaction Choice Time Test (4CRT) as a measure for recovery of the psychomotor function in patients after general anesthesia. One hundred female patients, scheduled to ambulatory gynecological surgery in general anesthesia, will be randomized to the group with pharmacological anxiolytic premedication with midazolam (N=50) and to the group without midazolam (N=50). All patients will be monitored using 4CRT before and after standardized general anesthesia. The reaction time, measured with 4CRT is the primary outcome parameter of the investigation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2016

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 5, 2014

Completed
1.5 years until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2019

Completed
Last Updated

January 11, 2021

Status Verified

January 1, 2021

Enrollment Period

3.3 years

First QC Date

August 28, 2014

Last Update Submit

January 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of four choice reaction time from baseline

    One time immediately before the surgery and 6 times within 2 hours after the surgery for each participant

    One time before the surgery and 2 hours after the surgery

Secondary Outcomes (1)

  • Concentration of midazolam in serum

    Within 2 hours after the surgery only in 40 (20 from each group) participants

Other Outcomes (1)

  • Postanesthesia discharge scoring system

    Within 2 hours after the surgery

Study Arms (2)

Standard therapy group

NO INTERVENTION

Participant who will not receive midazolam for pharmacological anxiolytic premedication before general surgery

Midazolam group

EXPERIMENTAL

Participant who will receive midazolam for pharmacological anxiolytic premedication before general surgery

Drug: Midazolam

Interventions

The participants receive the pharmacological premedication before the surgery anyway

Also known as: Dormicum
Midazolam group

Eligibility Criteria

Age19 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Physical status I-III according to American Society of Anesthesiology
  • ambulatory gynecologic surgery of 10-40 min
  • patient is able to use VAS and to use SmartPhone-based 4CRT
  • given informed consent

You may not qualify if:

  • age \< 18 or \> 50 years
  • patients who are not able to give their informed consent
  • surgery lasts more than 40 min.
  • history of psychopharmaceuticals or analgesics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Therapy

Dresden, Saxony, 01067, Germany

Location

Related Publications (1)

  • Zuurmond WW, Balk VA, van Dis H, van Leeuwen L, Paul EA. Multidimensionality of psychological recovery from anaesthesia. Analysing six recovery tests. Anaesthesia. 1989 Nov;44(11):889-92. doi: 10.1111/j.1365-2044.1989.tb09141.x.

    PMID: 2596654BACKGROUND

MeSH Terms

Conditions

Delayed Emergence from Anesthesia

Interventions

Midazolam

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Taras I Usichenko, MD, PhD

    University Medicine of Greifswald

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2014

First Posted

September 5, 2014

Study Start

March 1, 2016

Primary Completion

June 25, 2019

Study Completion

June 25, 2019

Last Updated

January 11, 2021

Record last verified: 2021-01

Locations